Back
Top 0.6%
22.9%
Top 0.8%
9.3%
Top 65%
8.0%
Top 2%
8.0%
Top 0.5%
6.1%
Top 27%
6.1%
Top 43%
6.1%
Top 2%
5.2%
Top 2%
4.3%
Top 2%
4.0%
Top 8%
2.0%
Top 2%
2.0%
Top 3%
1.6%
Top 3%
1.4%
Top 3%
1.4%
Top 2%
1.0%
Top 54%
0.7%
Top 22%
0.7%
Left ventricular function and clinical outcomes according to vericiguat and sacubitril/valsartan use in heart failure with nonpreserved ejection fraction: a real-world study
2026-02-01
cardiovascular medicine
Title + abstract only
View on medRxiv
Show abstract
Structured AbstractO_ST_ABSBackgroundC_ST_ABSVericiguat and sacubitril/valsartan both modulate the nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate signaling pathway and may improve myocardial function in patients with heart failure. ObjectivesTo compare the effects of vericiguat, sacubitril/valsartan, and their combination on left ventricular function and clinical outcomes in heart failure with nonpreserved ejection fraction patients. MethodsIn this retrospective real-wor...
Predicted journal destinations
1
Journal of the American Heart Association
92 training papers
2
Frontiers in Cardiovascular Medicine
33 training papers
3
PLOS ONE
1737 training papers
4
Circulation
37 training papers
5
The American Journal of Cardiology
15 training papers
6
BMJ Open
553 training papers
7
Scientific Reports
701 training papers
8
Circulation: Genomic and Precision Medicine
30 training papers
9
Open Heart
18 training papers
10
Heart Rhythm
16 training papers
11
Journal of Clinical Medicine
77 training papers
12
European Heart Journal - Digital Health
15 training papers
13
Hypertension
20 training papers
14
Medicine
29 training papers
15
Atherosclerosis
16 training papers
16
Frontiers in Physiology
18 training papers
17
eLife
262 training papers
18
Cureus
64 training papers